Lv3
380 积分 2023-07-28 加入
Anti–PD-1 Monoclonal Antibody Combined With Anti-VEGF Agent Is Safe and Effective in Patients With Recurrent/Metastatic Head and Neck Squamous Cancer as Second-Line or Beyond Treatment
12天前
已完结
Gemcitabine Combined With Apatinib and Toripalimab in Recurrent or Metastatic Nasopharyngeal Carcinoma
18天前
已完结
Mechanisms of Resistance to PD-1 Checkpoint Blockade
1个月前
已完结
An investigative meta-analysis on the effectiveness and safety of integrating VEGF/VEGFR inhibitors with PD-1/PD-L1 inhibitors in cases with R/M HNSCC
1个月前
已完结
First‐line immunotherapy combinations for recurrent or metastatic nasopharyngeal carcinoma: An updated network meta‐analysis and cost‐effectiveness analysis
1个月前
已完结
Quality of life and sexuality with penile prosthesis: a systematic review and pooled analysis
1个月前
已完结
The efficacy and safety of VEGF/VEGFR inhibitors in patients with recurrent or metastatic nasopharyngeal carcinoma: A meta-analysis
1个月前
已完结
Efficacy and Safety of Cell-based Immunotherapy in The Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma – A Systematic Review and Meta-analysis
1个月前
已完结
Quality of life and sexuality with penile prosthesis: a systematic review and pooled analysis
1个月前
已完结
Treatment Protocols in the Efficacy and Safety of Anti-EGFR Medicines in Combination with Standard Therapy for Patients with Nasopharyngeal Cancer: A Meta-Analysis
1个月前
已完结
皖公网安备34019202002308
